Jodie L. Lockhart, Group Vice President of Government Affairs & Legislative Policy, has been with the firm since 2002. Ms. Lockhart focuses on the development, advocacy and implementation of policies on behalf of life sciences companies, through both legislative and regulatory means. She maintains strong relationships with members and legislative staff on the House Energy & Commerce and Ways & Means Committees, as well as Senate Health, Education, Labor & Pensions (HELP) and Finance Committees. Since joining the firm, Ms. Lockhart has lobbied on a number of medical device, biotechnology, and pharmaceutical issues, including provisions in the Patient Protection and Affordable Care Act (PPACA), the Food and Drug Administration Amendments Act (FDAAA), the Medicare, Medicaid and SCHIP Extension Act, the Deficit Reduction Act (DRA), the Medical Device User Fee Modernization Act (MDUFMA), and the Medicare Modernization Act (MMA).
Ms. Lockhart served as Executive Director of the Coalition for Dialysis Patient Choice from 2005 to 2007. In this capacity she managed all federal activity for the Coalition including submitting hearing testimony, identifying sponsors and co-sponsors for legislation, and representing the Coalition in meetings with Members of Congress and their staff, as well as policy-makers within the Administration.
Ms. Lockhart previously worked in corporate communications for Healthcare Realty Trust, a Real Estate Investment Trust (REIT) in Nashville, TN. She received her Bachelor of Science, Summa Cum Laude from Vanderbilt University with concentrations in Economics and Mathematics. She holds her Master of Public Health in Health Policy from George Washington University.